CEACAM5 and cirrhosis of liver: In the Liver cirrhosis group (group B), 53 out of the 237 patients tested positive for elevated AFP (22.4%); 6 tested positive for AFP and CEA (2.5%); 15 tested positive for AFP and CA19-9 (6.8%); and none tested positive for AFP, CA19-9 and CEA (0%).